Predictions
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.39
08.07.21
08.07.21
-
08.07.22
08.07.22
13.98%
08.07.22
08.07.22
Enwave Corporation
Start price
Target price
Perf. (%)
€0.71
01.07.21
01.07.21
€1.10
01.07.22
01.07.22
-35.41%
02.07.22
02.07.22
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.23
28.06.21
28.06.21
-
28.06.22
28.06.22
-24.89%
29.06.22
29.06.22
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€1.38
28.06.21
28.06.21
€2.50
28.06.22
28.06.22
-71.16%
29.06.22
29.06.22
Canopy Growth Corp
Start price
Target price
Perf. (%)
€5.57
16.03.22
16.03.22
€6.90
16.03.23
16.03.23
-37.18%
11.06.22
11.06.22
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.23
28.05.22
28.05.22
-
28.05.23
28.05.23
-9.57%
11.06.22
11.06.22
NeutriSci International Inc
Start price
Target price
Perf. (%)
€0.020
06.05.22
06.05.22
-
06.06.22
06.06.22
33.00%
07.06.22
07.06.22
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.89
14.05.22
14.05.22
-
14.05.23
14.05.23
-13.51%
28.05.22
28.05.22
Canopy Growth Corp
Start price
Target price
Perf. (%)
€5.79
14.05.22
14.05.22
-
14.05.23
14.05.23
-20.54%
28.05.22
28.05.22
Risky Investment
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€9.52
27.05.21
27.05.21
€32.00
27.05.22
27.05.22
-55.61%
28.05.22
28.05.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Very Future proof/growth oriented business model
Antibe Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.48
08.07.21
08.07.21
-
08.07.22
08.07.22
-80.56%
21.05.22
21.05.22
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€5.45
30.04.22
30.04.22
-
30.04.23
30.04.23
-10.35%
14.05.22
14.05.22
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€40.00
20.11.21
20.11.21
-
20.11.22
20.11.22
-52.74%
11.05.22
11.05.22
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.96
06.03.22
06.03.22
-
06.03.23
06.03.23
9.97%
30.04.22
30.04.22
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.94
06.03.22
06.03.22
-
06.03.23
06.03.23
-0.02%
30.04.22
30.04.22
Risky Investment
Canopy Growth Corp
Start price
Target price
Perf. (%)
€5.70
18.04.22
18.04.22
-
18.04.23
18.04.23
-3.95%
30.04.22
30.04.22
Could be very worthwhile Investment >20% year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.03
11.11.21
11.11.21
€2.90
11.11.22
11.11.22
-21.78%
28.04.22
28.04.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.71
15.07.21
15.07.21
-
15.07.22
15.07.22
1.92%
23.04.22
23.04.22
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€1.15
21.03.22
21.03.22
€4.00
21.03.23
21.03.23
11.30%
04.04.22
04.04.22